Company Info
Phone(781) 786-8230
Year Established
2018
Ticker
DYN
Exchange
NASDAQ
Contacts
John Cox, MBAPresident & CEO
Francesco Bibbiani, M.D.
Senior VP, Head of Development
Susanna High, MBA
COO
Wildon Farwell, M.D., MPH
CMO
Oxana Beskrovnaya, Ph.D.
CSO
Jonathan McNeill, M.D.
CBO
John Najim, MBA
CTO
Company Description
Dyne Therapeutics is building a leading muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases.
